SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for EXELON CORP (EXC) (CIK 0001109357) (EXC) — Feb 23, 2016

EXELON CORP (EXC) (CIK 0001109357)
Date: Feb. 23, 2016 · CIK: 0001109357 · Accession: 0000000000-16-065899

AI Filing Summary & Sentiment

File numbers found in text: 333-209209

Date
February 22, 2016
Author
/s/ Lisa M. Kohl for
Form
UPLOAD
Company
EXELON CORP (EXC) (CIK 0001109357)

Letter

Mail Stop 3561 February 22, 2016 Jonathan W. Thayer Senior Executive Vice President and Chief Financial Officer Exelon Corporation 10 South Dearborn Street P.O. Box 805379 Chicago, Illinois 60680 -5379

Re: Exelon Corporation Registration Statement on Form S-4 Filed January 29, 2016 File No. 333-209209

Dear Mr. Thayer :

We have limited our review of your registration statement to those issues we have addressed in our comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our com ments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, w e may have additional comments.

General

1. Item 19 of Form S -4 identifies certain information to be provided in an exchange offer. We note that your most recently filed Form 10 -K incorporates by reference your definitive proxy statement, which you have n ot yet filed. Please either disclose in the Form S -4 all the information that Item 19 requires you to disclose, file the definitive proxy statement, or amend your Form 10 -K to include this information. Please refer to Securities Act Forms Compliance and Disclosure Interpretation 123.01, by analogy.

Jonathan W. Thayer Exelon Corporation February 22, 2016 Page 2

Signatures, II -4

2. Please revise your signature page to include the signature of your principal financial officer in his individual capacity . Please r efer to Instruction 1 to Signatures on Form S-4. In this regard, we note that Mr. Thayer signed the first half of your signature page on behalf of the registrant but not in his individual capacity.

Index of Exhibits

Opinion of Ballard Spahr LLP, Exhibit 5.2

3. We note counsel ’s statement that their opinion , directed to the board, may not be relied upon or distributed to any o ther person without prior written consent from counsel . Please have counsel revise the opinion to eliminate this limitation on reliance. For guidance, refer to Section II.B.3.d of Staf f Legal Bulletin No. 19 (CF) (Oct. 14, 2011).

We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 193 3 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.

Notwithstanding our comments, in the event you request acceleration of the effective date of the pending registration statement , please provide a written statement from the company acknowledging that:

 should the Commission or the staff, acting pursuant to delegated authority, declare th e filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Jonathan W. Thayer Exelon Corporation February 22, 2016 Page 3

Please refer to Rules 460 and 461 regarding requests for acceleration . We will consider a written request for acceleration of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the securities specified in the above registration statement. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

Please contact Danilo Castelli , Attorney Advisor at (202) 551 -6521 , Lisa Kohl, Legal Branch Chief at (202) 551-3252 or me at (202) 551 - 3264 with any other questions.

Sincerely,
/s/ Lisa M. Kohl for

Show Raw Text
Mail Stop 3561

February 22, 2016

Jonathan W. Thayer
Senior  Executive  Vice President and Chief Financial Officer
Exelon Corporation
10 South Dearborn Street
P.O. Box 805379
Chicago, Illinois 60680 -5379

Re: Exelon Corporation
  Registration Statement on Form S-4
Filed  January 29, 2016
  File No.  333-209209

Dear Mr. Thayer :

We have limited our review of your registration statement to those issues we have
addressed in our comments.  In  some of our comments, we may ask you to provide us with
information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the
requested information .  If you do not believe our com ments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.

After reviewing any amendment to your registration statement and the information you
provide in response to these  comments, w e may have  additional comments.

General

1. Item 19 of Form S -4 identifies certain information to be provided in an exchange
offer.  We note that your most recently filed Form 10 -K incorporates by reference
your definitive proxy statement, which you have n ot yet filed.  Please either disclose
in the Form S -4 all the information that Item 19 requires you to disclose, file the
definitive proxy statement, or amend your Form 10 -K to include this information.
Please refer to Securities Act Forms Compliance and Disclosure Interpretation
123.01, by analogy.

Jonathan W. Thayer
Exelon Corporation
February 22, 2016
Page 2

 Signatures, II -4

2. Please revise your signature page to include the signature of your principal financial
officer  in his individual capacity .  Please r efer to Instruction 1 to Signatures on Form
S-4.  In this regard, we note that Mr. Thayer signed the first half of your signature
page on behalf of the registrant but not in his individual capacity.

Index of Exhibits

Opinion of Ballard Spahr LLP, Exhibit 5.2

3. We note counsel ’s statement that their opinion , directed to the board, may not be
relied upon or distributed to any o ther person without  prior written consent  from
counsel . Please have counsel revise  the opinion to eliminate this  limitation on
reliance.  For guidance, refer to Section II.B.3.d of Staf f Legal Bulletin No. 19 (CF)
(Oct. 14, 2011).

We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Act of 193 3 and
all applicable Securities  Act rules require.   Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.

Notwithstanding our comments, in  the event you request acceleration of the effective date
of the pending registration statement , please provide a written statement from the company
acknowledging that:

 should the Commission or the staff, acting pursuant to delegated authority, declare th e
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;

 the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company  from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

 the company may not assert staff comments and the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under  the federal
securities laws of the United States.

Jonathan W. Thayer
Exelon Corporation
February 22, 2016
Page 3

 Please refer to Rules 460 and 461 regarding requests for  acceleration .  We will consider a
written request for acceleration of the effective date of the registration statement as confirmation
of the fact that those requesting acceleration are aware of their respective responsibilities under
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed
public offering of the securities specified in the above registration statement.  Please allow
adequate time  for us to review any amendment prior to the requested effective date of the
registration statement.

Please contact Danilo Castelli , Attorney Advisor  at (202) 551 -6521 , Lisa Kohl, Legal
Branch Chief at (202) 551-3252  or me at (202) 551 - 3264  with any other questions.

Sincerely,

 /s/ Lisa M. Kohl for

 Mara Ransom
Assistant Director
Office of Consumer Products

cc: Bruce G. Wilson
 Richard  B. Aftanas, P .C.